Overview

Treatment of Adult ADHD With Atomoxetine or Atomoxetine and Buspar

Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
Determine if there is a difference in treatment response for adults with ADHD who are treated with Strattera versus those treated with a combination of Strattera and buspirone
Phase:
Phase 2
Details
Lead Sponsor:
Pfizer
Treatments:
Atomoxetine Hydrochloride
Buspirone